Accellacare-Wilmington — Wilmington, North Carolina

Accellacare-Wilmington is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Accellacare-Wilmington has participated in 37 clinical trials with 13 currently active.

Therapeutic areas: COVID-19, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a).

Sponsors: Pfizer, Eli Lilly and Company, Biosion, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wilmington

Browse all research sites in North Carolina · View every site in Wilmington

• New Hanover Regional Hospital
• Betty Cameron Women & Children's Hospital
• PMG Research of Wilmington
• Research Site
• GSK Investigational Site
• Trial Management Associates
• New Hanover Regional Medical Center
• Accellacare
• Novant Health New Hanover Regional Medical Center
• Novo Nordisk Investigational Site
• Wilmington Dermatology Center

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare-Wilmington?

Accellacare-Wilmington has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare-Wilmington conducted?

Accellacare-Wilmington has 37 clinical trials on record, with 13 currently active. Their work covers COVID-19, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a).

Is Accellacare-Wilmington accredited by Crixeo Clinical Trials?

Accellacare-Wilmington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accellacare-Wilmington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.